Icosagen (Estonia)
Icosagen is an Estonian biotechnology companies providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2004 to 2024. Read More.
Open Access Percentage
77%
Total
Publications
75
Total Open
Publications
58
Total
Citations
1.3K
Open Access
Percentage
77%
Total
Publications
75
Total Open
Publications
58
Total
Citations
1.3K
Breakdown
Publisher Open
15%
Both
54%
Other Platform Open
8%
Closed
23%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 59%
31
Hybrid 33%
17
No Guarantees 8%
4
Other Platform Open
Domain 77%
36
Institution 26%
12
Other Internet 17%
8
Public 15%
7
Preprint 11%
5
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 36 |
Europe PMC | Domain | 17 |
Semantic Scholar | Public | 7 |
KU Leuven - Lirias | Institution | 6 |
University of Oslo - Duo Research Archive | Institution | 4 |
DOI | Other Internet | 4 |
Maastricht University - Research Publications | Institution | 3 |
bioRxiv | Preprint | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |